Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott H James

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|December 22, 2017
Pathogenesis of Non-Zika Congenital Viral InfectionsSuresh B Boppana, William J Britt, Karen Fowler, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Filociclovir Is a Potent <i>In Vitro</i> and <i>In Vivo</i> Inhibitor of Human AdenovirusesKaroly Toth, Islam T M Hussein, Ann E Tollefson, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2011
Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinaseScott H James, Caroll B Hartline, Emma A Harden, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-AnalysisCamila Aparicio, Zachary I Willis, Mari M Nakamura, et al.
Journal of the Pediatric Infectious Diseases Society|May 23, 2024
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-AnalysisCamila Aparicio, Zachary I Willis, Mari M Nakamura, et al.
Open Forum Infectious Diseases|November 29, 2024
Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive MessagingMolly L Paras, Lisa M Chirch, Mariam Aziz, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Synthesis of USC-093 and comparison with its promoiety enantiomer USC-093D against adenovirus in vitro and in a Syrian hamster modelJiayi Yang, Samantha B Riemann, Jinglei Lyu, et al.
Journal of the Pediatric Infectious Diseases Society|October 9, 2023
Pediatric Infectious Diseases Milestones: A Step in the Right Direction to Evaluate Subspecialty LearnersSanya J Thomas, Marsha S Anderson, Elisabeth E Adderson, et al.
Antiviral Research|December 13, 2022
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirusAndrea J Parsons, Sabrina I Ophir, Thomas J Gardner, et al.
The Journal of Pediatrics|November 7, 2025
ReplyYoungNa Lee-Kim, Lisa DelSignore, Nicholas J Antos, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|December 22, 2017
Pathogenesis of Non-Zika Congenital Viral InfectionsSuresh B Boppana, William J Britt, Karen Fowler, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Filociclovir Is a Potent <i>In Vitro</i> and <i>In Vivo</i> Inhibitor of Human AdenovirusesKaroly Toth, Islam T M Hussein, Ann E Tollefson, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2011
Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinaseScott H James, Caroll B Hartline, Emma A Harden, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-AnalysisCamila Aparicio, Zachary I Willis, Mari M Nakamura, et al.
Journal of the Pediatric Infectious Diseases Society|May 23, 2024
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-AnalysisCamila Aparicio, Zachary I Willis, Mari M Nakamura, et al.
Open Forum Infectious Diseases|November 29, 2024
Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive MessagingMolly L Paras, Lisa M Chirch, Mariam Aziz, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Synthesis of USC-093 and comparison with its promoiety enantiomer USC-093D against adenovirus in vitro and in a Syrian hamster modelJiayi Yang, Samantha B Riemann, Jinglei Lyu, et al.
Journal of the Pediatric Infectious Diseases Society|October 9, 2023
Pediatric Infectious Diseases Milestones: A Step in the Right Direction to Evaluate Subspecialty LearnersSanya J Thomas, Marsha S Anderson, Elisabeth E Adderson, et al.
Antiviral Research|December 13, 2022
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirusAndrea J Parsons, Sabrina I Ophir, Thomas J Gardner, et al.
The Journal of Pediatrics|November 7, 2025
ReplyYoungNa Lee-Kim, Lisa DelSignore, Nicholas J Antos, et al.
Pageof 6